Patent · US Active

Progestogen-only oral contraception

US11679114B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Navad Life Sciences Pte · SG

Inventors

Michael Oettel · Jena, DE
Hermann Osterwald · Glückstadt, DE
Prithi S. Kochhar · New Delhi, IN

Key dates

Filing date	Jul 26, 2021
Grant date	Jun 20, 2023
Priority date	—
Expiry date	Jul 28, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2095
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for providing progestogen only contraception.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.